E2 has been shown to significantly inhibit the malignant behavior of HCC cells through the up-regulation of NLRP3 inflammasomes mediated by the ERβ/MAPK signal pathway (40). The gene discussed is NLRP3; the disease is hepatocellular carcinoma.